ATE421996T1 - Verfahren zur herstellung optisch aktiver n- carbamat-geschützter beta-lactame durch optische auflösung unter verwendung einer candida antarctica lipase - Google Patents

Verfahren zur herstellung optisch aktiver n- carbamat-geschützter beta-lactame durch optische auflösung unter verwendung einer candida antarctica lipase

Info

Publication number
ATE421996T1
ATE421996T1 AT05826088T AT05826088T ATE421996T1 AT E421996 T1 ATE421996 T1 AT E421996T1 AT 05826088 T AT05826088 T AT 05826088T AT 05826088 T AT05826088 T AT 05826088T AT E421996 T1 ATE421996 T1 AT E421996T1
Authority
AT
Austria
Prior art keywords
candida antarctica
lactame
optically active
protected beta
producing optically
Prior art date
Application number
AT05826088T
Other languages
German (de)
English (en)
Inventor
Ankush Argade
Original Assignee
Rigel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rigel Pharmaceuticals Inc filed Critical Rigel Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE421996T1 publication Critical patent/ATE421996T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10Nitrogen as only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/04Alpha- or beta- amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/006Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT05826088T 2004-11-15 2005-11-15 Verfahren zur herstellung optisch aktiver n- carbamat-geschützter beta-lactame durch optische auflösung unter verwendung einer candida antarctica lipase ATE421996T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62840104P 2004-11-15 2004-11-15

Publications (1)

Publication Number Publication Date
ATE421996T1 true ATE421996T1 (de) 2009-02-15

Family

ID=36190809

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05826088T ATE421996T1 (de) 2004-11-15 2005-11-15 Verfahren zur herstellung optisch aktiver n- carbamat-geschützter beta-lactame durch optische auflösung unter verwendung einer candida antarctica lipase

Country Status (10)

Country Link
US (1) US7459301B2 (https=)
EP (1) EP1812581B1 (https=)
JP (1) JP4738416B2 (https=)
AT (1) ATE421996T1 (https=)
CA (1) CA2580151C (https=)
DE (1) DE602005012597D1 (https=)
DK (1) DK1812581T3 (https=)
ES (1) ES2320364T3 (https=)
PT (1) PT1812581E (https=)
WO (1) WO2006055528A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1763514A2 (en) * 2004-05-18 2007-03-21 Rigel Pharmaceuticals, Inc. Cycloalkyl substituted pyrimidinediamine compounds and their uses
GB2420559B (en) * 2004-11-15 2008-08-06 Rigel Pharmaceuticals Inc Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses
JP5400388B2 (ja) 2005-12-15 2014-01-29 ライジェル ファーマシューティカルズ, インコーポレイテッド キナーゼインヒビターおよびその利用
HU227663B1 (en) * 2007-07-09 2011-10-28 Univ Szegedi Resolution process
RU2535032C2 (ru) 2008-12-22 2014-12-10 Милленниум Фармасьютикалз, Инк. Сочетание ингибиторов аврора киназы и анти-cd 20 антител
EP2489663A1 (en) 2011-02-16 2012-08-22 Almirall, S.A. Compounds as syk kinase inhibitors
EP3076963A4 (en) 2013-12-06 2017-09-13 Millennium Pharmaceuticals, Inc. Combination of aurora kinase inhibitors and anti-cd30 antibodies
JP2018524292A (ja) 2015-07-21 2018-08-30 ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. オーロラキナーゼインヒビターと化学療法剤の投与
US11874276B2 (en) 2018-04-05 2024-01-16 Dana-Farber Cancer Institute, Inc. STING levels as a biomarker for cancer immunotherapy
WO2019201279A1 (zh) * 2018-04-18 2019-10-24 广东东阳光药业有限公司 一种桥环化合物的制备方法
US20220305048A1 (en) 2019-08-26 2022-09-29 Dana-Farber Cancer Institute, Inc. Use of heparin to promote type 1 interferon signaling

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002520027A (ja) * 1998-07-09 2002-07-09 ロンザ ア−ゲ− (1r,4s)−2−アザビシクロ[2.2.1]ヘプタ−5−エン−3−オン誘導体の製造方法

Also Published As

Publication number Publication date
PT1812581E (pt) 2009-04-22
EP1812581B1 (en) 2009-01-28
DK1812581T3 (da) 2009-05-11
CA2580151A1 (en) 2006-05-26
JP2008520206A (ja) 2008-06-19
ES2320364T3 (es) 2009-05-21
JP4738416B2 (ja) 2011-08-03
US20060166308A1 (en) 2006-07-27
WO2006055528A2 (en) 2006-05-26
CA2580151C (en) 2014-02-04
DE602005012597D1 (de) 2009-03-19
EP1812581A2 (en) 2007-08-01
WO2006055528A3 (en) 2006-08-31
US7459301B2 (en) 2008-12-02

Similar Documents

Publication Publication Date Title
ATE421996T1 (de) Verfahren zur herstellung optisch aktiver n- carbamat-geschützter beta-lactame durch optische auflösung unter verwendung einer candida antarctica lipase
Gotor Biocatalysis applied to the preparation of pharmaceuticals
ATE474910T1 (de) L-glutaminsäure produzierender mikroorganismus sowie verfahren zur produktion von l- glutaminsäure
GB2425759A (en) Cover system for a transfer trailer
ATE535141T1 (de) Verfahren zur modifikation von pflanzlicher biomasse
DE69914458D1 (de) Verfahren zur enzymatischen auflösung von laktamen
DK1543147T3 (da) Fremgangsmåde til påvisning af methicillinresistente Staphylococcus aureus
DE59813589D1 (de) Verfahren zur Herstellung von optisch aktiven Aminoalkoholen durch Racematspaltung
ATE452186T1 (de) Cephalosporin-c-acylase-mutante und verfahren zur herstellung von 7-aca damit
WO2005005633A3 (en) Methods for the stereoselective synthesis and enantiomeric enrichment of b-amino acids
ATE488597T1 (de) Verfahren zur herstellung optisch aktiver aminosäuren unter verwendung eines ganzzellenkatalysators
ATE283348T1 (de) Verfahren zur herstellung von aminoalkoholen und derivaten davon
DE50312796D1 (de) Verfahren zur herstellung von isocyanaten
ATE459723T1 (de) Verfahren zur herstellung von (4s)-3,4-dihydroxy- 2,6,6-trimethyl-cyclohex-2-enon und derivaten davon unter verwendung der azoarcus phenylethanol dehydrogenase
ATE134610T1 (de) Verfahren zur herstellung von optisch aktiven 4- amino-3-hydroxycarbonsäuren
ATE332391T1 (de) Verfahren zur enzymatischen herstellung enantiomerenangereicherter beta-aminosäuren
ATE319836T1 (de) Verfahren zur herstellung von l-aminosäuren aus ihren racemischen n-acetyl-d,l-derivaten durch enzymatische racemat-spaltung mittels isolierter, rekombinanter enzyme
ATE362543T1 (de) Verfahren zur herstellung von optisch aktiven beta-amino alkoholen
ATE312197T1 (de) Verfahren zur enantioselektiven herstellung von sekundären alkoholen durch lipasenkatalysierte solvolyse der korrespondierenden acetessigester
ATE176931T1 (de) Verfahren zur enzymatischen herstellung von optisch aktiven estern einer transglycidsäure
ATE304606T1 (de) Verfahren zur enzymatischen herstellung von enantiomerenreinen 1,3-dioxolan-4-on- und 1,3- oxathiolan-5-on-derivaten
ATE466688T1 (de) Verfahren zur herstellung von bauteilen
DE602005002146D1 (de) Verfahren zur mikrobiologischen Herstellung von optisch aktiven 3-Chlor-2-methyl-1,2-propandiol
ATE401416T1 (de) Verfahren zur herstellung von optisch aktiver n- geschützten propargylglycine
DE502005002868D1 (de) Verfahren zur enantioselektiven öffnung von 3-substituierten oxetan-2-onen unter verwendung der lipasen von candida antarctica oder von burkholderia plantarii

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1812581

Country of ref document: EP